 - Patients with documented disease of the central nervous system that can interfere with the trial assessments, including but not limited to stroke, tumor, Parkinsons, organic brain disease, seizure disorder except for febrile convulsions during infancy, chronic infection, or neurosyphilis; or patients who have suffered a traumatic brain injury resulting in significant impairment 